Literature DB >> 15597200

Modeling the E. coli 4-hydroxybenzoic acid oligoprenyltransferase ( ubiA transferase) and characterization of potential active sites.

Lars Bräuer1, Wolfgang Brandt, Ludger A Wessjohann.   

Abstract

4-hydroxybenzoate oligoprenyltransferase of E. coli, encoded in the gene ubiA, is an important key enzyme in the biosynthetic pathway to ubiquinone. It catalyzes the prenylation of 4-hydroxybenzoic acid in position 3 using an oligoprenyl diphosphate as a second substrate. Up to now, no X-ray structure of this oligoprenyltransferase or any structurally related enzyme is known. Knowledge of the tertiary structure and possible active sites is, however, essential for understanding the catalysis mechanism and the substrate specificity. With homology modeling techniques, secondary structure prediction tools, molecular dynamics simulations, and energy optimizations, a model with two putative active sites could be created and refined. One active site selected to be the most likely one for the docking of oligoprenyl diphosphate and 4-hydroxybenzoic acid is located near the N-terminus of the enzyme. It is widely accepted that residues forming an active site are usually evolutionary conserved within a family of enzymes. Multiple alignments of a multitude of related proteins clearly showed 100% conservation of the amino acid residues that form the first putative active site and therefore strongly support this hypothesis. However, an additional highly conserved region in the amino acid sequence of the ubiA enzyme could be detected, which also can be considered a putative (or rudimentary) active site. This site is characterized by a high sequence similarity to the aforementioned site and may give some hints regarding the evolutionary origin of the ubiA enzyme. Semiempirical quantum mechanical PM3 calculations have been performed to investigate the thermodynamics and kinetics of the catalysis mechanism. These results suggest a near S(N)1 mechanism for the cleavage of the diphosphate ion from the isoprenyl unit. The 4-hydroxybenzoic acid interestingly appears not to be activated as benzoate anion but rather as phenolate anion to allow attack of the isoprenyl cation to the phenolate, which appeared to be the rate limiting step of the whole process according to our quantum chemical calculations. Our models are a basis for developing inhibitors of this enzyme, which is crucial for bacterial aerobic metabolism. [figure: see text]. Structure of the model of ubiA oligoprenyltransferase derived from the photosynthetic reaction center (1PRC). Putative active amino acid residues and substrates are shown as capped sticks to describe their location and geometry in the putative active sites. The violet spheres identify Mg2+.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15597200     DOI: 10.1007/s00894-004-0197-6

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  18 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000.

Authors:  A Bairoch; R Apweiler
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

3.  Cloning and sequencing of Escherichia coli ubiC and purification of chorismate lyase.

Authors:  B P Nichols; J M Green
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

4.  Ubiquinone biosynthesis. Cloning of the genes coding for chorismate pyruvate-lyase and 4-hydroxybenzoate octaprenyl transferase from Escherichia coli.

Authors:  M Siebert; A Bechthold; M Melzer; U May; U Berger; G Schröder; J Schröder; K Severin; L Heide
Journal:  FEBS Lett       Date:  1992-08-03       Impact factor: 4.124

5.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

6.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria.

Authors:  T Fechteler; U Dengler; D Schomburg
Journal:  J Mol Biol       Date:  1995-10-13       Impact factor: 5.469

8.  Characterization of polyprenyldiphosphate: 4-hydroxybenzoate polyprenyltransferase from Escherichia coli.

Authors:  M Melzer; L Heide
Journal:  Biochim Biophys Acta       Date:  1994-04-14

9.  Yeast farnesyl-diphosphate synthase: site-directed mutagenesis of residues in highly conserved prenyltransferase domains I and II.

Authors:  L Song; C D Poulter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  COQ2 is a candidate for the structural gene encoding para-hydroxybenzoate:polyprenyltransferase.

Authors:  M N Ashby; S Y Kutsunai; S Ackerman; A Tzagoloff; P A Edwards
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

View more
  12 in total

Review 1.  What can a chemist learn from nature's macrocycles?--a brief, conceptual view.

Authors:  Ludger A Wessjohann; Eelco Ruijter; Daniel Garcia-Rivera; Wolfgang Brandt
Journal:  Mol Divers       Date:  2005       Impact factor: 2.943

2.  Methods for Structural and Functional Analyses of Intramembrane Prenyltransferases in the UbiA Superfamily.

Authors:  Y Yang; N Ke; S Liu; W Li
Journal:  Methods Enzymol       Date:  2016-12-07       Impact factor: 1.600

3.  Structural insights into ubiquinone biosynthesis in membranes.

Authors:  Wei Cheng; Weikai Li
Journal:  Science       Date:  2014-02-21       Impact factor: 47.728

4.  UBIAD1-mediated vitamin K2 synthesis is required for vascular endothelial cell survival and development.

Authors:  Jeffrey M Hegarty; Hongbo Yang; Neil C Chi
Journal:  Development       Date:  2013-04       Impact factor: 6.868

5.  UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy.

Authors:  Michael L Nickerson; Brittany N Kostiha; Wolfgang Brandt; William Fredericks; Ke-Ping Xu; Fu-Shin Yu; Bert Gold; James Chodosh; Marc Goldberg; Da Wen Lu; Masakazu Yamada; Timo M Tervo; Richard Grutzmacher; Chris Croasdale; Maria Hoeltzenbein; John Sutphin; S Bruce Malkowicz; Ludger Wessjohann; Howard S Kruth; Michael Dean; Jayne S Weiss
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

6.  Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence.

Authors:  Rakesh K Dhiman; Sebabrata Mahapatra; Richard A Slayden; Melissa E Boyne; Anne Lenaerts; Jerald C Hinshaw; Shiva K Angala; Delphi Chatterjee; Kallolmay Biswas; Prabagaran Narayanasamy; Michio Kurosu; Dean C Crick
Journal:  Mol Microbiol       Date:  2009-02-11       Impact factor: 3.501

7.  The pds2 mutation is a lesion in the Arabidopsis homogentisate solanesyltransferase gene involved in plastoquinone biosynthesis.

Authors:  Li Tian; Dean DellaPenna; Richard A Dixon
Journal:  Planta       Date:  2007-06-14       Impact factor: 4.116

8.  Terpene biosynthesis in glandular trichomes of hop.

Authors:  Guodong Wang; Li Tian; Naveed Aziz; Pierre Broun; Xinbin Dai; Ji He; Andrew King; Patrick X Zhao; Richard A Dixon
Journal:  Plant Physiol       Date:  2008-09-05       Impact factor: 8.340

9.  The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase.

Authors:  Marc M Schumacher; Rania Elsabrouty; Joachim Seemann; Youngah Jo; Russell A DeBose-Boyd
Journal:  Elife       Date:  2015-03-05       Impact factor: 8.140

10.  Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy.

Authors:  Andrew Orr; Marie-Pierre Dubé; Julien Marcadier; Haiyan Jiang; Antonio Federico; Stanley George; Christopher Seamone; David Andrews; Paul Dubord; Simon Holland; Sylvie Provost; Vanessa Mongrain; Susan Evans; Brent Higgins; Sharen Bowman; Duane Guernsey; Mark Samuels
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.